Novartis, synthetic vaccines company in influenza deal

Novartis AG (NYSE:NVS; SIX:NOVN) and Synthetic Genomics Vaccines Inc. (San Diego, Calif.) partnered to use synthetic genomics technologies to develop synthetically constructed influenza seed viruses f...